News Releases


08 August 2019
Opened Cronos Device Labs , New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire State-of-the-Art Fermentation Facility Established New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform  TORONTO








News Releases

08 August 2019
Opened Cronos Device Labs , New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire State-of-the-Art Fermentation Facility Established New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform  TORONTO
09 July 2019
36-Year CPG Executive Brings Extensive Experience in Identifying, Developing and Commercializing Breakthrough Technology for Consumer Goods Sector TORONTO , July 09, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that Dr.
08 July 2019
TORONTO , July 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc.  (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results for the second quarter ended June 30, 2019, and hold its Second Quarter 2019 Earnings Conference Call on Thursday, August 8,
19 June 2019
TORONTO , June 19, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 shareholders voting in person or by proxy holding in total 261,290,314 common shares,
29 May 2019
TORONTO , May 29, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), an innovative global cannabinoid company, will hold its 2019 Annual Meeting of Shareholders on Wednesday, June 19, 2019 at 10 a.m.
14 May 2019
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement  TORONTO , May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to announce that it has entered into a multi-year supply agreement with
09 May 2019
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs , a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to Cultivate Psychoactive Cannabis in Colombia Spinach™ Partners with Arrive Alive DRIVE SOBER® Cronos Group
07 May 2019
Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO , May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it is expanding its global infrastructure
08 March 2019

TORONTO , March 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (NYSE: MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group . Altria also has a warrant to acquire additional ownership in Cronos Group , which is exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55% and provide Cronos Group with additional proceeds of approximately C$1.4 billion .

04 March 2019
TORONTO , March 04, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation (" Whistler "), representing approximately 19 percent
23 January 2019
TORONTO , Jan. 23, 2019 /PRNewswire/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (" Cronos Group " or the " Company ") today announced that it has entered into a credit agreement (the " Credit Agreement ") with Canadian Imperial Bank of Commerce (" CIBC "), as administrative agent and